Heather Behanna

Director, Entasis Therapeutics.

Companies

Design Therapeutics, Inc.Board member Jun 16, 2021 to now¹
Entasis TherapeuticsBoard member Sep 25, 2018 to Jul 11, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Design Therapeutics, Inc. DSGN1,300 shares³$13.4K at $10.31Mar 25, 2024
Entasis Therapeutics0 shares⁴Jul 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 25, 2024Bought 1,300 shares at $3.74 of Design Therapeutics, Inc.³
Jul 11, 2022Returned to company 27,500 shares at $2.20 of Entasis Therapeutics⁴
Jul 7, 2022U 22,000 shares at $2.20 of Entasis Therapeutics⁴
Jan 18, 2022Granted 27,500 shares of Entasis Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDesign Therapeutics, Inc., Board member
2
SEC EDGAREntasis Therapeutics, Board member
3
SEC EDGARDesign Therapeutics, Inc. shares after the filing of Mar 25, 2024
4
SEC EDGAREntasis Therapeutics shares after the filing of Jul 11, 2022
5
SEC EDGARForm 4 filed Jan 19, 2022